Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Jan-24 5:50 PM View:  | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 05-Jan-24 | Sale | 898 | $22.78 | $20,456.40 | (3%) 28.72K to 27.82K | |
| 02-Jan-24 4:29 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 29-Dec-23 | Option Exercise | 8,000 | $6.18 | $49,440.00 | 42% 19.07K to 27.07K | |
| 22-Dec-23 2:31 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 21-Dec-23 | Sale (Planned) | 2,500 | $21.68 | $54,200.00 | (14%) 17.52K to 15.02K | |
| 29-Nov-23 2:29 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 28-Nov-23 | Sale (Planned) | 1,500 | $13.72 | $20,580.00 | (8%) 19.02K to 17.52K | |
| 04-Oct-23 6:29 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 03-Oct-23 | Sale (Planned) | 2,500 | $15.77 | $39,425.00 | (12%) 21.29K to 18.79K | |
| 22-Aug-23 12:19 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 18-Aug-23 | Sale (Planned) | 2,500 | $18.92 | $47,300.00 | (11%) 23.79K to 21.29K | |
| 03-Aug-23 2:34 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 28-Jul-23 | Option Exercise | 460 | $12.00 | $5,520.00 | 2% 23.33K to 23.79K | |
| 27-Jun-23 12:14 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 23-Jun-23 | Option Exercise | 920 | $12.00 | $11,040.00 | 4% 22.41K to 23.33K | |
| 20-Apr-23 2:17 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 19-Apr-23 | Sale (Planned) | 5,000 | $18.88 | $94,400.00 | (19%) 25.99K to 20.99K | |
| 14-Apr-23 6:25 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 13-Apr-23 | Option Exercise | 460 | $12.00 | $5,520.00 | 2% 21.92K to 22.38K | |
| 15-Mar-23 10:00 PM View: | Robbins Wendye Director | Rapt Therapeutics, Inc. (RAPT) | 14-Mar-23 | Private Purchase | 2,500 | $18.99 | $47,487.00 | 11% 22.5K to 25.0K | |
| 15-Mar-23 10:00 PM View: | Robbins Wendye Director | Rapt Therapeutics, Inc. (RAPT) | 14-Mar-23 | Purchase | 2,500 | $20.05 | $50,125.00 | 10% 25.0K to 27.5K | |
| 13-Mar-23 2:21 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 07-Mar-23 | Market Sale (Planned) | 5,000 | $29.62 | $148,100.00 | (16%) 30.53K to 25.53K | (11%) |
| 06-Mar-23 2:25 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 03-Mar-23 | Option Exercise | 460 | $12.00 | $5,520.00 | 2% 30.07K to 30.53K | |
| 26-Jan-23 2:29 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 24-Jan-23 | Market Sale (Planned) | 5,000 | $30.00 | $150,000.00 | (14%) 35.07K to 30.07K | (10%) |
| 20-Jan-23 6:33 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 19-Jan-23 | Sale (Planned) | 5,000 | $25.56 | $127,800.00 | (12%) 40.07K to 35.07K | |
| 17-Jan-23 4:10 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 12-Jan-23 | Option Exercise | 2,422 | $9.55 | $23,124.60 | 6% 37.65K to 40.07K | |
| 09-Jan-23 3:17 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 05-Jan-23 | Sale | 742 | $21.97 | $16,298.80 | (4%) 19.81K to 19.07K | |
| 30-Dec-22 6:57 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 29-Dec-22 | Sale (Planned) | 5,000 | $18.03 | $90,150.00 | (12%) 42.65K to 37.65K | |
| 29-Nov-22 2:49 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 28-Nov-22 | Sale (Planned) | 5,000 | $17.87 | $89,350.00 | (10%) 47.65K to 42.65K | |
| 03-Nov-22 6:44 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 02-Nov-22 | Sale (Planned) | 5,000 | $22.32 | $111,600.00 | (9%) 52.65K to 47.65K | |
| 14-Oct-22 2:41 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 13-Oct-22 | Sale (Planned) | 2,000 | $21.52 | $43,040.00 | (4%) 54.65K to 52.65K | |
| 04-Oct-22 12:47 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 03-Oct-22 | Option Exercise | 807 | $9.55 | $7,706.10 | 1% 53.84K to 54.65K | |
| 06-Sep-22 7:55 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 01-Sep-22 | Option Exercise | 808 | $9.55 | $7,712.40 | 2% 53.03K to 53.84K | |
| 31-Aug-22 2:33 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 30-Aug-22 | Sale (Planned) | 2,500 | $28.13 | $70,325.00 | (5%) 55.53K to 53.03K | |
| 15-Aug-22 5:48 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 12-Aug-22 | Option Exercise | 807 | $9.55 | $7,706.10 | 1% 54.73K to 55.53K | |
| 13-Jul-22 5:33 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Jul-22 | Option Exercise | 2,422 | $9.55 | $23,130.30 | 4% 54.31K to 56.73K | |
| 13-Jul-22 5:33 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Jul-22 | Option Sale | 2,000 | $19.95 | $39,900.00 | (4%) 56.73K to 54.73K | |
| 27-May-22 4:29 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 25-May-22 | Private Purchase | 1,900 | $12.45 | $23,664.30 | < 1% 4.42M to 4.43M | |
| 27-May-22 10:00 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 25-May-22 | Private Purchase Duplicate | 1,900 | $12.45 | $23,664.30 | < 1% 4.42M to 4.43M | |
| 25-May-22 4:19 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 24-May-22 | Purchase Duplicate | 16,314 | $12.00 | $195,802.00 | < 1% 4.41M to 4.42M | |
| 25-May-22 4:20 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 24-May-22 | Purchase | 16,314 | $12.00 | $195,802.00 | < 1% 4.41M to 4.42M | |
| 25-May-22 4:20 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 23-May-22 | Private Purchase | 10,236 | $12.50 | $127,943.00 | < 1% 4.4M to 4.41M | |
| 25-May-22 4:19 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 23-May-22 | Private Purchase Duplicate | 10,236 | $12.50 | $127,943.00 | < 1% 4.4M to 4.41M | |
| 12-May-22 4:59 PM View: | Robbins Wendye Director | Rapt Therapeutics, Inc. (RAPT) | 10-May-22 | Purchase | 2,500 | $10.68 | $26,702.00 | 14% 17.41K to 19.91K | |
| 12-May-22 5:28 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 10-May-22 | Private Purchase | 1,250,000 | $10.67 | $13,339,400.00 | 40% 3.15M to 4.4M | |
| 12-May-22 5:00 PM View: | Young Rodney Kb Chief Financial Officer | Rapt Therapeutics, Inc. (RAPT) | 10-May-22 | Private Purchase | 5,000 | $10.53 | $52,650.00 | 98% 5.08K to 10.08K | |
| 12-May-22 5:29 PM View: | Column Group Ii, Lp 10% Owner | Rapt Therapeutics, Inc. (RAPT) | 10-May-22 | Private Purchase Duplicate | 1,250,000 | $10.67 | $13,339,400.00 | 40% 3.15M to 4.4M | |
| 12-May-22 4:59 PM View: | Robbins Wendye Director | Rapt Therapeutics, Inc. (RAPT) | 10-May-22 | Private Purchase | 4,500 | $11.24 | $50,580.00 | 35% 12.9K to 17.41K | |
| 05-May-22 1:28 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 04-May-22 | Sale (Planned) | 720 | $15.05 | $10,836.00 | (4%) 20.53K to 19.81K | |
| 12-Apr-22 7:05 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Apr-22 | Planned Option Sale | 2,647 | $23.05 | $61,013.30 | (12%) 22.46K to 19.81K | |
| 12-Apr-22 7:05 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Apr-22 | Option Exercise | 2,647 | $6.18 | $16,358.50 | 13% 19.81K to 22.46K | |
| 12-Apr-22 7:04 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Apr-22 | Option Exercise | 920 | $12.00 | $11,040.00 | 2% 53.39K to 54.31K | |
| 07-Apr-22 3:25 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 06-Apr-22 | Sale (Planned) | 3,000 | $22.96 | $68,880.00 | (5%) 56.39K to 53.39K | |
| 04-Apr-22 7:29 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 04-Apr-22 | Option Exercise | 695 | $6.30 | $4,378.50 | 1% 55.69K to 56.39K | |
| 14-Mar-22 4:53 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Mar-22 | Planned Option Sale | 2,648 | $23.91 | $63,313.70 | (12%) 22.46K to 19.81K | |
| 14-Mar-22 4:53 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Mar-22 | Option Exercise | 2,648 | $6.18 | $16,364.60 | 13% 19.81K to 22.46K | |
| 28-Feb-22 8:34 PM View: | Ho William Chief Medical Officer | Rapt Therapeutics, Inc. (RAPT) | 28-Feb-22 | Sale (Planned) | 3,000 | $18.79 | $56,370.00 | (5%) 58.69K to 55.69K | |
| 14-Feb-22 3:09 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Feb-22 | Planned Option Sale | 2,647 | $22.47 | $59,478.10 | (12%) 22.46K to 19.81K | |
| 14-Feb-22 3:09 PM View: | Brockstedt Dirk G. Chief Scientific Officer | Rapt Therapeutics, Inc. (RAPT) | 11-Feb-22 | Option Exercise | 2,647 | $6.18 | $16,358.50 | 13% 19.81K to 22.46K |
